1 |
Kuwajerwala, N., Cifuentes, E., Gautam, S., Menon, M., Barrack, E. R. and Reddy, G. P. 2002. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis. Cancer Res. 62, 2488-2492.
|
2 |
Martindale, J. L. and Holbrook, N. J. 2002. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell Physiol. 192, 1-15.
DOI
|
3 |
Ohgaki, H. and Kleihues, P. 2005. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J. Neuropathol. Exp. Neurol. 64, 479-489.
DOI
|
4 |
Ren, W., Qiao, Z., Wang, H., Zhu, L. and Zhang, L. 2003. Flavonoids: promising anticancer agents. Med. Res. Rev. 23, 519-534.
DOI
|
5 |
Shankar, S., Singh, G. and Srivastava, R. K. 2007. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front. Biosci. 12, 4839-4854.
DOI
|
6 |
Siddiqui, I. A., Sanna, V., Ahmad, N., Sechi, M. and Mukhtar, H. 2015. Resveratrol nanoformulation for cancer prevention and therapy. Ann. NY Acad. Sci. 1348, 20-31.
DOI
|
7 |
Yang, J. H., Hsia, T. C., Kuo, H. M., Chao, P. D., Chou, C. C., Wei, Y. H. and Chung, J. G. 2006. Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug. Metab. Dispos. 34, 296-304.
|
8 |
Zulueta, A., Caretti, A., Signorelli, P. and Ghidoni, R. 2015. Resveratrol: A potential challenger against gastric cancer. World J. Gastroenterol. 21, 10636-10643.
DOI
|
9 |
Jiang, H., Zhang, L., Kuo, J., Kuo, K., Gautam, S. C., Groc, L., Rodriguez, A. I., Koubi, D., Hunter, T. J., Corcoran, G. B., Seidman, M. D. and Levine, R. A. 2005. Resveratrol-induced apoptotic death in human U251 glioma cells. Mol. Cancer Ther. 4, 554-561.
DOI
|
10 |
Joe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D. and Weinstein, I. B. 2002. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8, 893-903.
|
11 |
Kanadaswami, C., Lee, L. T., Lee, P. P., Hwang, J. J., Ke, F. C., Huang, Y. T. and Lee, M. T. 2005. The antitumor activities of flavonoids. In Vivo 19, 895-909.
|
12 |
Kao, C. L., Huang, P. I., Tsai, P. H., Tsai, M. L., Lo, J. F., Lee, Y. Y., Chen, Y. J., Chen, Y. W. and Chiou, S. H. 2009. Resveratrol-induced apoptosis and increased radiosensitivity in CD133-positive cells derived from atypical teratoid/rhabdoid tumor. Int. J. Radiat. Oncol. Biol. Phys. 74, 219-228.
DOI
|
13 |
Kim, E. J., Choi, C. H., Park, J. Y., Kang, S. K. and Kim, Y. K. 2008. Underlying mechanism of quercetin-induced cell death in human glioma cells. Neurochem. Res. 33, 971-979.
DOI
|
14 |
Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S. and Takada, Y. 2004. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24, 2783-2840.
|
15 |
Kim, K. W., Choi, C. H., Kim, T. H., Kwon, C. H., Woo, J. S. and Kim, Y. K. 2009. Silibinin inhibits glioma cell proliferation via Ca2+/ROS/MAPK-dependent mechanism in vitro and glioma tumor growth in vivo. Neurochem. Res. 34, 1479-1490.
DOI
|
16 |
Kma, L. 2013. Synergistic effect of resveratrol and radiotherapy in control of cancers. Asian Pac. J. Cancer Prev. 14, 6197-6208.
DOI
|
17 |
Kundu, J. K. and Surh, Y. J. 2008. Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives. Cancer Lett. 269, 243-261.
DOI
|
18 |
Bhardwaj, A., Sethi, G., Vadhan-Raj, S., Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A. S., Shishodia, S. and Aggarwal, B. B. 2007. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109, 2293-2302.
DOI
|
19 |
Clement, M. V., Hirpara, J. L., Chawdhury, S. H. and Pervaiz, S. 1998. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996-1002.
|
20 |
Cobb, M. H. 1999. MAP kinase pathways. Prog. Biophys. Mol. Biol. 71, 479-500.
DOI
|
21 |
Cohen, G. M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326, 1-16.
DOI
|
22 |
DeAngelis, L. M. 2001. Brain tumors. N. Engl. J. Med. 344, 114-123.
DOI
|
23 |
Jeong, J. C., Kim, M. S., Kim, T. H. and Kim, Y. K. 2009. Kaempferol induces cell death through ERK and Akt-dependent down-regulation of XIAP and survivin in human glioma cells. Neurochem. Res. 34, 991-1001.
DOI
|
24 |
Fresco, P., Borges, F., Diniz, C. and Marques, M. P. 2006. New insights on the anticancer properties of dietary polyphenols. Med. Res. Rev. 26, 747-766.
DOI
|